Termination times (out of 200 msec.) for all studied cases. حسب Cyrille Grébonval (11457171)

Number of counties used for the null model analysis by prediction year for 2004–2021. حسب Alexander C. Keyel (6791771)

The carotid canal area is larger on the unaffected side than on the affected side in patients with unilateral moyamoya disease, but the difference decreases according to the contra... حسب Yuki Oichi (11840776)

"…The ratio decreases according to the development of contralateral ICA stenosis in all cases. (C) shows a representative case of contralateral progression of unilateral moyamoya disease. …"

Clinical and epidemiological information on all MRSA cases in Norway 2008–2017. حسب Torunn Gresdal Rønning (13021167)

Table1_The role of glucocorticoids in increasing cardiovascular risk.docx حسب Hai-Wei Deng (16493715)

"…</p>Conclusions<p>Administration of GCs is possibly related with increased risk for MACE, CHD, and HF but not increased all-cause death or stroke. …"

Image1_The role of glucocorticoids in increasing cardiovascular risk.tiff حسب Hai-Wei Deng (16493715)

"…</p>Conclusions<p>Administration of GCs is possibly related with increased risk for MACE, CHD, and HF but not increased all-cause death or stroke. …"

Image2_The role of glucocorticoids in increasing cardiovascular risk.tiff حسب Hai-Wei Deng (16493715)

"…</p>Conclusions<p>Administration of GCs is possibly related with increased risk for MACE, CHD, and HF but not increased all-cause death or stroke. …"

Table3_The role of glucocorticoids in increasing cardiovascular risk.doc حسب Hai-Wei Deng (16493715)

"…</p>Conclusions<p>Administration of GCs is possibly related with increased risk for MACE, CHD, and HF but not increased all-cause death or stroke. …"

Table2_The role of glucocorticoids in increasing cardiovascular risk.doc حسب Hai-Wei Deng (16493715)

"…</p>Conclusions<p>Administration of GCs is possibly related with increased risk for MACE, CHD, and HF but not increased all-cause death or stroke. …"

Predicted number of cases averted. حسب Andromachi Karachaliou Prasinou (22145688)

"…<p>Plot showing the number of cases averted over a 25 year time period predicted by the model against the number of required vaccine doses increasing the target age group incrementally from 1-14 years to include 15-19 year olds and then 20-29 year olds. …"

Study area– 19 provinces of southern Vietnam. حسب Anne-Frieda Taurel (655558)

"…In recent times, an increase in the age of cases with clinical dengue has been reported in the national surveillance system and published literature of Vietnam. …"

During electrical stimulation the decrease in compound action potential (CAP), but not of ATP, is larger in <i>Plp</i>^null/y mice. حسب Andrea Trevisiol (9647910)

Biases in larger populations. حسب Sander W. Keemink (21253563)

"…<p>(<b>A</b>) Maximum absolute bias vs the number of neurons in the population for the Bayesian decoder. Bias decreases with increasing neurons in the population. …"

<i>News24</i>, ‘Estimated TB cases in SA’, published on 31 October 2022. حسب Marnell Kirsten (20765824)

Represents a single case of a patient developing AKI during the first 24 hours of a hospital stay. حسب Lorenzo Ruinelli (13014138)

Trends in the all-age numbers and age-standardized incidence, prevalence, mortality and DALYs rates of PUD by sex from 1990 to 2021. حسب Wende Hao (10315597)

الموضوعات:

Increased adherence to treatment guidelines in patients with urinary tract infection in primary care: A retrospective study حسب Helena Kornfält Isberg (6523931)

"…The use of recommended nitrofurantoin or pivmecillinam in LUTI in women increased from 54% in 2008 to 69% in 2013. Fluoroquinolones or trimethoprim were prescribed in 24% of LUTI cases in women in 2008 and in 7% of cases in 2013. …"

Forest map of univariate meta-analysis of all-cause mortality. حسب Linna Zhao (492404)

NVT IPD cases: Best fitting model prediction under the base case, LAIV, NVT FOI, and NVT CCR increase scenarios compared with NVT data for all ages. حسب Yoon Hong Choi (52781)

Annual cases of TB projected for 2017–2065, for LTBI test and treat strategies targeted to those with medical risk factors, the non-USB, both of these groups, and all (universal), for 2, 4, and 10-fold increases in testing rates. حسب Alex J. Goodell (6569636)